HealthDay News — For warfarin-treated patients, carbamazepine co-treatment is associated with subtherapeutic anticoagulative effect and increased warfarin dose requirements, according to a study ...

Friday, June 7, 2024. News & Perspective Drugs & Diseases CME & Education Video Decision Point Drugs & Diseases CME & Education Video Decision Point ...

Gene analysis failed in a U.S. clinical trial to help doctors select better doses of warfarin, the widely used blood-thinner, which can cause dangerous bleeding if doses are too high and fail to ...

A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society ...

Race influences warfarin dose Date: May 29, 2015 Source: American Society of Hematology Summary: A new report demonstrates that clinical and genetic factors affecting dose requirements for ...

Among women with atrial fibrillation at elevated CV risk, treatment with high-dose edoxaban vs. warfarin conferred greater reduction in hemorrhagic stroke and major bleeding compared with men ...

A fixed-dose of dabigatran, a new oral thrombin inhibitor, for the treatment of patients with acute venous thromboembolism had similar safety and efficacy to warfarin, according to investigators ...

The gene-guided dosing strategy of warfarin generally leads to over-dose in patients at doses lower than 2 mg/kg, and only 50% of individual variability in daily stable doses can be explained. In ...

Feb. 19 -- WEDNESDAY, Feb. 18 (HealthDay News) -- A DNA test could make prescribing the widely used anticoagulant warfarin safer by predicting the lowest effective dose, a new study finds. The U.S ...

Six community hospitals of various sizes, representing a total of 1,952 inpatient beds and approximately 83,000 admissions per year, participated in the project. The hospitals were geographically ...